A Novel Substrate Mimetic Inhibitor of PKB/Akt Inhibits Prostate Cancer Tumor Growth in Mice by Blocking the PKB Pathway
- 31 March 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (16) , 4716-4724
- https://doi.org/10.1021/bi061928s
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomasJournal of Neuro-Oncology, 2005
- Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancerInternational Journal of Cancer, 2003
- Faculty disclosureSeminars in Oncology, 2003
- Current strategies in the management of hormone refractory prostate cancerCancer Treatment Reviews, 2003
- Chemotherapy for prostate cancerUrology, 2002
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Frequent Loss of PTEN Expression Is Linked to Elevated Phosphorylated Akt Levels, but Not Associated with p27 and Cyclin D1 Expression, in Primary Epithelial Ovarian CarcinomasThe American Journal of Pathology, 2001
- Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 StudyJournal of Clinical Oncology, 1999
- Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer LinesJournal of Biological Chemistry, 1999
- Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report.Journal of Clinical Oncology, 1994